Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in CGC — Canopy Growth Corp

CIK 1000275 TORONTO, A6
Back to CGC Full portfolio

Position in CGC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,027,862
+$101,671 QoQ
Shares Held
1,081,963
+10.9% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 212 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGC Over Time

Shares Held

Position Value (USD)

Derivatives in CGC

reported options exposure · as of Sep 30, 2024
CallValue
$964,000
CallShares
200,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $624,876,791 across 66 Drug Manufacturers - Specialty & Generic names. CGC ranks #19 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RDY
Dr Reddys Laboratories Ltd
 9,213,269 $133,500,266
2 ZTS
Zoetis Inc.
 1,828,326 $131,383,499
3 NBIX
Neurocrine Biosciences Inc
 583,476 $98,339,041
4 BHC
Bausch Health Companies Inc.
 10,832,582 $53,404,627
5 VTRS
Viatris Inc
 3,135,460 $49,791,098
6 UTHR
UNITED THERAPEUTICS Corp
 62,600 $33,918,552
7 TEVA
Teva Pharmaceutical Industries Ltd
 953,413 $32,301,629
8 HLN
Haleon plc
 3,385,489 $31,586,609

All Filings in CGC

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,027,862 1,081,963
2026-03-31 $926,191 975,967
2025-12-31 $91,525 80,287
2025-09-30 $649,255 444,697
2025-06-30 $1,570,499 1,287,295
2025-03-31 $49,254 54,127
2024-12-31 $167,053 60,969
2024-09-30 $964,000 200,000
2024-09-30 $253,394 52,572
2024-06-30 $5,547,000 860,000
2024-06-30 $1,124,026 174,268
2024-06-30 $2,451,000 380,000
2024-03-31 $14,671,000 1,700,000
2024-03-31 $1,726,000 200,000
2024-03-31 $10,843,592 1,256,500
2023-12-31 $264,854 51,831
2023-09-30 $438,340 559,825
2023-06-30 $261,326 673,531
2023-03-31 $341,660 195,236
2022-12-31 $1,085,700 470,000
2022-12-31 $453,983 196,531
2022-09-30 $1,283,100 470,000
2022-09-30 $577,435 211,516
2022-06-30 $615,040 215,805
2022-06-30 $1,054,500 370,000
2022-03-31 $8,577,652 1,131,617
2022-03-31 $3,658,866 482,700
2022-03-31 $227,400 30,000
2021-12-31 $21,631,243 2,477,806
2021-12-31 $5,315,697 608,900
2021-09-30 $4,851,000 350,000
2021-09-30 $38,304,586 2,763,679
2021-06-30 $11,986,026 495,700
2021-06-30 $61,509,973 2,543,837
2021-06-30 $9,430,200 390,000
2021-03-31 $89,596,363 2,797,264
2021-03-31 $10,272,021 320,700
2021-03-31 $2,882,700 90,000
2020-12-31 $12,196,800 495,000
2020-12-31 $10,780,000 437,500
2020-12-31 $33,309,235 1,351,836
2020-09-30 $4,439,200 310,000
2020-09-30 $4,976,200 347,500
2020-09-30 $13,177,848 920,241
2020-06-30 $13,695,600 847,500
2020-06-30 $24,509,254 1,516,662
2020-06-30 $5,252,000 325,000
2020-03-31 $28,279,809 1,961,152
2020-03-31 $5,335,400 370,000
2020-03-31 $8,615,950 597,500

Report a Problem

Category
Description
Email (optional, for follow-up)